Title : Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese population.

Pub. Date : 2021 Aug

PMID : 33688781






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Peripheral T-cell lymphoma (PTCL) is a group of aggressive lymphomas commonly treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Prednisone DNA damage inducible transcript 3 Homo sapiens